Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Searching for fast money? Discover the best places to sell items for quick cash and get paid almost instantly.
15,258 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Stellantis unveiled a bold €60 billion turnaround plan at Investor Day, aiming to reshape costs, cash flow, and a mod...
IMAX bucked trend as cinema operators fade; investors eye the premium-format chain's sale.
Mid-career jobseekers are trimming resumes and curating online profiles as hiring cools and AI filters tighten. The t...
A big strategic shift from Lilly could redefine how investors view weight-loss drugs. This article breaks down what h...
A narrow, theme-driven ETF focused on generative AI shows mixed results as broader AI funds rally. The concentrated a...
Former President Donald Trump publicly supports CFTC Chair Michael Selig's push to widen federal control over predict...
Micron stock has surged as AI memory demand grows. With a gain of 214% this year, late investors wonder if now is the...
A growing share of managers treat AI as teammates and even show them on org charts, but new research links this to ac...
A single platform now powers a large share of global digital infrastructure, triggering merger chatter and forcing in...
As markets shift in May 2026, a popular plan to generate $4,800 per year from $40,000 in dividend stocks faces realit...
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...